Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02858674 · ClinicalTrials.gov registry record · NA
Health Information Technology in Heart Failure Care
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 958
- Enrollment target
NCT02858674: Completed NA study, sponsored by NYU Langone Health.
NCT02858674 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 958 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02858674, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 958 participants
- Enrollment target
Study Summary
The objective of this proposal is to develop, implement, and test the effectiveness of a computerized clinical decision support system for hospitalized patients with heart failure. Aim 1: Develop an electronic health record (EHR) based search method that uses both structured data and natural language processing of unstructured text to identify hospitalized patients with heart failure while they are still in the hospital. Aim 2: Develop and test the usability of an electronic health record (EHR) based clinical decision support system (CDSS) to support delivery of evidence-based care to hospitalized heart failure patients using human computer interaction methods. Aim 3: Assess the effect of an electronic health record (EHR) based clinical decision support system (CDSS) on processes of care for heart failure patients who are hospitalized for other causes. As part of the evaluation, we will test two implementation strategies, one of which will introduce the CDSS as an interruptive alert to providers, the second of which will introduce the CDSS as part of a provider checklist that exists on the side of the screen for each patient.
Primary Outcome
These patients will also have had of left ventricular function (LV) Assessment either prior to or during the hospitalization or planned for post discharge
Interventions
- OTHER Pop Up Interruption Alert
- OTHER Side Bar Non Interruptive Provider Checklist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 958 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
What the finished NCT02858674 record still lists
NCT02858674 is an interventional study that assigns participants to a tested intervention. The registered 958 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (32% lower).
The record links to 0 conditions, and to 2 interventions - of which Pop Up Interruption Alert is the first listed.
NCT02858674 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02858674 about?
NCT02858674 is a clinical study titled "Health Information Technology in Heart Failure Care". The objective of this proposal is to develop, implement, and test the effectiveness of a computerized clinical decision support system for hospitalized patients with heart failure. Aim 1: Develop an electronic health record (EHR) based search method that uses both structured data and natural langua...
What is the current status of trial NCT02858674?
This trial is currently completed. It is a NA study. The enrollment target is 958 participants. The study started on 2017-04-01. Estimated completion is 2018-03-31.
What interventions are being tested in trial NCT02858674?
The interventions under investigation include: Pop Up Interruption Alert (OTHER), Side Bar Non Interruptive Provider Checklist (OTHER).
Who is sponsoring clinical trial NCT02858674?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02858674's enrollment target sits among peer trials
958 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI